Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
6500-81-8
Molecular formula
C13H11Cl2NaO4
Molecular weight
325.12 g/mol
Drug class
Loop diureticethacrynic acid derivative
Mechanism of action
Ethacrynate sodium dissociates to ethacrynic acid, a loop diuretic that inhibits the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle, reducing sodium and chloride reabsorption and increasing urinary excretion of sodium, chloride, potassium and water.
Indications / reported uses
Treatment of oedema associated with congestive heart failure, hepatic cirrhosis or renal disease, including nephrotic syndrome.
Intravenous use for acute pulmonary oedema or situations requiring rapid diuresis, under the product label.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Etacrynate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Etacrynate Permitted Daily Exposure (PDE) report (the Etacrynate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Etacrynate Occupational Exposure Limit (OEL) report (the Etacrynate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.